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The transcriptional coactivator TAZ recognizes L/PPxY motifs in transcription factors like Runx1/2
through its WW domain. We show that the ﬁrst PDZ domain of zona occludens-1 (ZO-1) and 2
(ZO-2) interacts with the carboxy-terminal PDZ binding motif of TAZ. Deletion of this motif abro-
gates binding. ZO-2 colocalizes with TAZ in the nucleus of MDCK cells and ZO-2 expression alters
TAZ localization in human embryonic kidney cells. Luciferase assays demonstrate ZO-2 inhibition
of TAZ-mediated transactivation. We propose that zonula occludens is a negative regulator of TAZ
and suggest that selected tight junction proteins control nuclear translocation and activity of TAZ.
Structured summary:
MINT-7994937: ZO-2 (uniprotkb:Q95168) binds (MI:0407) to TAZ (uniprotkb:Q9EPK5) by pull down
(MI:0096)
MINT-7994900, MINT-7994835, MINT-7994885: ZO-1 (uniprotkb:Q07157) physically interacts (MI:0915)
with TAZ (uniprotkb:Q9EPK5) by pull down (MI:0096)
MINT-7995020: ZO-2 (uniprotkb:Q9UDY2) and TAZ (uniprotkb:Q9GZV5) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7994953: ZO-1 (uniprotkb:Q07157) binds (MI:0407) to TAZ (uniprotkb:Q9EPK5) by pull down
(MI:0096)
MINT-7994970: TAZ (uniprotkb:73990382) and ZO-2 (uniprotkb:Q95168) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7994867: TAZ (uniprotkb:Q9EPK5) physically interacts (MI:0915) with ZO-2 (uniprotkb:Q9UDY2)
by pull down (MI:0096)
MINT-7994988: TAZ (uniprotkb:Q9GZV5) and ZO-1 (uniprotkb:Q07157) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7994999: TAZ (uniprotkb:Q9EPK5) and ZO-2 (uniprotkb:Q95168) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7994922, MINT-7994853: ZO-2 (uniprotkb:Q95168) physically interacts (MI:0915) with TAZ (uni-
protkb:Q9EPK5) by pull down (MI:0096)
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otein; GFP, green ﬂuorescent
n embryonic kidney; MDCK,
density95-discs large-zonula
Z binding motif; ZO-1/ZO-2,
have been deposited in the
Protein Research, VIB, B-9000
ans).1. Introduction
TAZ (transcriptional coactivator with PDZ binding motif), also
known as WWTR1 (WW domain containing transcription regulator
1) was ﬁrst identiﬁed as a 14-3-3 binding protein and is a paralog
of YAP (Yes-associated protein) [1]. Both TAZ and YAP share a
strongly conserved carboxy-terminal postsynaptic density95-discs
large-zonula occludens (PDZ) binding motif (-FLTWL). Since they
lack a DNA binding domain, stimulation of gene expression islsevier B.V. All rights reserved.
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in transcription factors. TAZ has been reported to bind Runx2 [2],
PPARc [3], and the TEF-1/TEAD family [4]. By consequence, TAZ
is implicated in several biological processes such as mesenchymal
stem cell differentiation [3], embryogenesis [5], cell proliferation
and promotion of epithelial-mesenchymal transition [6]. TAZ also
plays a role in cancer [7].
The mechanisms that control functions of YAP and TAZ are
starting to be elucidated. Both proteins are part of the Hippo path-
way originally identiﬁed in Drosophila [8]. All known components
of this kinase cascade are highly conserved in vertebrates where
they are also responsible for controlling tissue and organ size by
coordinating proliferation and apoptosis. TAZ activity is also
regulated by its C-terminal PDZ binding motif that is indispensable
for TAZ-stimulated gene transcription and accumulation into nu-
clear foci [1]. Currently, the only known PDZ domain containing
interaction partner for TAZ is NHERF-2 (Na+/H+ exchanger regula-
tory factor), a polypeptide that tethers plasma membrane ion
channels and receptors to cytoskeletal actin. TAZ speciﬁcally asso-
ciates to the ﬁrst PDZ domain of NHERF-2, whereas YAP interacts
with the second PDZ domain [9].
Although the importance of the PDZ binding motif of TAZ is
clearly acknowledged, the PDZ protein responsible for regulation
of TAZ localization and function is not known. Several junction-
associated proteins are not solely conﬁned at the plasma mem-
brane but belong to a growing class of nucleo-junctional proteins
that shuttle between the junction and the nucleus [10]. This is
illustrated by the interaction of ZO-2 with the transcription factors
Fos, Jun and CCAAT/enhancer binding protein [11]. These tight
junction proteins are promising candidates to transmit signals
from the membrane and cytoskeleton to the nucleus, thereby
potentially regulating TAZ-mediated transcription. Here we report
the interaction between TAZ and Zonula Occludens-1 and -2 (ZO-
1/-2). These ligands also interact with YAP [12].
2. Materials and methods
2.1. Antibodies
Custom made rabbit polyclonal antibodies for human TAZ were
generated (Supplementary Fig. 1). Rabbit anti-green ﬂuorescentFig. 1. Interaction between ZO proteins and TAZ is established through recognition of t
GST–TAZ wild-type (WT), GST–TAZ without the PDZ binding motif (TAZ DPDZ) and GFP
lysates (top panels, input) show expression of transfected constructs. Immunoblotting w
TAZ (middle panels, pull down) in contrast to mutant TAZ lacking the C-terminal PDZ bi
with asterisks highlighting ZO-1 and ZO-2. (B) GST pull down from HEK cells transfected
with polyclonal anti-ZO-1 (left panel) and ZO-2 antibodies (right panel) showing interac
proteins is shown in the upper panel.protein (GFP) was from Santa Cruz (Santa Cruz, California, USA).
Rabbit anti-ZO-1, rabbit anti-ZO-2, mouse anti-ZO-1 and mouse
anti-ZO-2 were from Invitrogen (Merelbeke, Belgium), mouse anti-
Myc from Millipore (Billerica, Massachusetts, USA), rat anti-HA
was from Roche and rabbit anti-glutathione-S-transferase (GST)
fromAbcam.All secondary antibodies used for immunoﬂuorescence
were obtained fromMolecular Probes (Merelbeke, Belgium).
2.2. Plasmids
Supplementary data.
2.3. Protein expression
GST–PDZ fusions were transformed into BL21(DE3) pLysS
cells. Cells were grown at 37 C in LB medium containing
50 lg/ml ampicillin. Protein expression was induced at 37 C
for 4 h with IPTG. The PDZ domains were puriﬁed by glutathione
sepharose afﬁnity chromatography according to instructions of
the manufacturer.
2.4. GST pull down, immunoprecipitation, and immunoblotting
HEK293T cells were transfected with eukaryotic expression vec-
tors for GST, GST–TAZ wild-type or GST–TAZ DPDZ, or co-transfec-
ted with GFP–ZO-1 or GFP–ZO-2. Cells were disrupted in ice-cold
lysis buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl, 1% Triton-
X100, 1 mM PMSF) and a protease inhibitor cocktail mix (Roche
Diagnostics, Mannheim, Germany). Insoluble material was
removed by centrifugation (20 000g for 15 min at 4 C). Cleared
extracts were incubated with gluthatione sepharose (GE Health-
care). Proteins were separated by SDS–PAGE and transferred to
nitrocellulose. For GST pull down assays, 10 lg of the GST fusion
proteins bound to glutathione sepharose beads were incubated at
4 C for 1 h with 1 mg cytoplasmic protein. Interacting proteins
were processed as described above.
2.5. Western blotting
Protein concentrations were determined by the method of
Bradford [13] using bovine serum albumin as a standard. Westernhe C-terminal PDZ binding motif. (A) HEK293T cells were co-transfected with GST,
–ZO-1 or GFP–ZO-2. Cell extracts were incubated with glutathione sepharose. Total
ith a polyclonal anti-GFP antibody reveals ZO-1 and ZO-2 binding to wild-type GST
nding motif. Sizes in kDa are indicated. Bottom panels show Coomassie stained gels
with GST, GST–TAZ WT and GST–TAZ DPDZ. Endogenous ZO proteins were detected
tion with the WT GST TAZ but not with GST TAZ DPDZ. The input of endogenous ZO
Fig. 2. Direct interaction between TAZ and the ﬁrst PDZ domain of ZO proteins. (A)
Lysate from HEK293T cells overexpressing Myc-TAZ was incubated with GST
fusions of the three single PDZ domains of ZO-1 and ZO-2 bound to glutathione
beads. Coprecipitating proteins were separated by SDS–PAGE. Myc-tagged TAZ was
identiﬁed by Western blot with a monoclonal anti-Myc antibody. (B) Incubation of
recombinant His6-TAZ with GST fusions of the ﬁrst PDZ domain of ZO-1 and ZO-2
bound to glutathione beads showing a direct interaction. PDZ2 of ZO-1 is included
as a negative control. SN = supernatants.
Fig. 3. Endogenous TAZ partially colocalizes with endogenous ZO-2 in the nucleus. (A an
(C and D) MCF10A breast cells were stained for TAZ (red) and ZO-1 (C) or ZO-2 (D) (gre
E. Remue et al. / FEBS Letters 584 (2010) 4175–4180 4177blotting was performed as described [14]. Proteins were visualized
by enhanced chemiluminescence detection (ECL, GE Healthcare).
2.6. Cell culture
Cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium + Glutamax (DMEM, Invitrogen), supplemented with 10%
fetal bovine serum (FBS, Invitrogen), 100 U/ml penicillin and
0.1 mg/ml streptomycin. MCF10A cells were maintained in a
DMEM/Ham F12 mixture (3/1), supplemented with horse serum
(Invitrogen), hydrocortisone (Sigma, St Louis,Missouri, USA), insulin
(Sigma), EGF (Invitrogen) and choleratoxin.
2.7. Immunostaining and microscopy
Cells were grown on glass coverslips, washed with PBS and
ﬁxed with 3.7% paraformaldehyde for 20 min at room temperature.
After permeabilization with 0.2% Triton X-100 in PBS, cells were
blocked in 1% BSA in PBS and incubated at 37 C with primary anti-
body for 1 h, followed by Alexa Fluor-488/594 goat anti-mouse/
rabbit IgG (Molecular Probes Eugene, Oregon, USA) for 30 min at
room temperature. Stained cells were examined using a Zeiss
Axioplan II epiﬂuorescence microscope. Images were capturedd B) MDCK cells stained for endogenous TAZ (red) and ZO-1 (A) or ZO-2 (B) (green).
en). Size bar = 20 lm.
4178 E. Remue et al. / FEBS Letters 584 (2010) 4175–4180using a cooled CCD Axiocam Camera and Axiovision 4.4 software
(Zeiss, Götingen, Germany).
2.8. Transient transcriptional activation assays
Supplementary data.
3. Results
3.1. TAZ associates with ZO-1 and ZO-2 through its C-terminal PDZ
binding motif
We fused TAZ to GST and used this fusion protein as an afﬁnity
probe following cotransfection of GST–TAZ with ZO-1/2 in
HEK293T cells. GFP-tagged ZO-1 and ZO-2 were speciﬁcally re-
tained by GST–TAZ (Fig. 1A, asterisks). To ascertain if the PDZ bind-
ing region of TAZ was required for this interaction we used a TAZ
construct that lacks 10 residues at the carboxy-terminus (GST–
TAZ DPDZ). Signiﬁcantly, neither ZO-1 nor ZO-2 was retained by
the TAZ mutant that lacked the PDZ binding motif. These ﬁndings
indicate that the carboxy-terminal PDZ binding motif of TAZ is re-
quired for binding with ZO-1 and ZO-2.
We next investigated whether GST–TAZ could also interact with
endogenous ZO-1 or ZO-2. GST, GST–TAZ WT and GST–TAZ DPDZ
were transfected in HEK293T followed by GST pull down and
immunoblotting with anti-zonula occludens -1/-2 (ZO-1/ZO-2)
antibodies (Fig. 1B). ZO-1 and ZO-2 signals were observed in lanes
representing GST–TAZ WT, in contrast to GST and GST–TAZ DPDZ.
These data indicate that ZO proteins recognize the C-terminal PDZ
binding motif of TAZ, most likely via one of their PDZ domains.Fig. 4. Inhibition of TAZ-dependent transcriptional activation by ZO-2. (A) HEK cells w
without ZO-2 WT or mutant ZO-2 lacking the ﬁrst PDZ domain. ZO-2 reduces TAZ-media
ﬁrst PDZ domain, still shows inhibition but to a lesser extent. (B) HEK cells were transfec
Luciferase transcription is activated through transfection of TAZ. This activation is poten
experiments.3.2. TAZ binds directly to the ﬁrst PDZ domain of ZO-1 and ZO-2
ZO proteins contain 3 PDZ domains organized in tandem array.
To determine which of these interact with TAZ, we transfected
HEK293T cells with N-terminally myc-tagged TAZ and incubated
the lysate with GST–PDZ1, GST–PDZ2 or GST–PDZ3 of ZO-1 and
-2 immobilized on glutathione beads. A clear signal was detected
only in the lane of the PDZ1 domain of ZO-1 or ZO-2 (Fig. 2A).
These results are consistent with a model in which the PDZ binding
motif of TAZ interacts with the PDZ1 domain of the ZO-proteins. To
test whether these proteins interact directly we incubated puriﬁed
recombinant GST–PDZ1–ZO-1 and GST–PDZ1–ZO-2, bound to glu-
tathione beads, with recombinant His6-TAZ present in a Escherichia
coli lysate. His6-TAZ interacts with the PDZ1 domain of ZO-1 or ZO-
2 but no interaction was observed with either GST or GST–PDZ2 of
ZO-1 (Fig. 2B) indicating that TAZ directly interacts with the ﬁrst
PDZ domain of ZO-1 and -2.
3.3. Colocalization of ZO-1/ZO-2 with TAZ
Weak TAZ staining was observed in the cytoplasm in Madin-
Darby canine kidney cells (MDCK) and MCF10A cells with more
prominent localization in the nucleus (Fig. 3A–D, middle panel).
ZO-1was primarily concentrated at cell–cell contacts inMDCK cells
as reported previously [15] (Fig. 3A and C, left panel). Weak cyto-
plasmic staining of ZO-1 was also observed in MCF10A cells but a
nuclear localization could not be detected (Fig. 3C, left panel). This
is in stark contrast to ZO-2 staining which displays a pronounced
nuclear accumulation in MDCK cells (Fig. 3B, left panel) in addition
to a cytosolic and plasma membrane staining pattern in MCF10Aere transfected with a luciferase reporter construct and Gal4-fused TAZ, with or
ted transcription activation in a dose-dependent manner. Mutant ZO-2, lacking the
ted with a luciferase reporter fused to the Runx2-responsive osteocalcin promotor.
tly reduced when ZO-2 is co-expressed. Results are the mean ± S.D. from 3 separate
E. Remue et al. / FEBS Letters 584 (2010) 4175–4180 4179(Fig. 3D, left panel). The nuclear staining pattern of TAZ and ZO-2
overlaps implying that both proteins partially colocalize in the nu-
cleus. Interaction between TAZ and ZO proteins is likely to be con-
text- and cell type dependent: CaCo-2 cells that were grown for
more than a week to promote the formation of functional tight
junctions [16] showed a strong colocalization between TAZ and
ZO-1 at the plasma membrane (Supplementary Fig. 2A). The stain-
ing pattern of ZO-1 in sparsely seeded MDA-MB 231 cells was quite
peculiar: ZO-1 was detected in the cytoplasm and occasionally also
in the nucleus. Intriguingly, ZO-1 colocalized with TAZ at the lead-
ing edge of migrating MDA cells (Supplementary Fig. 2B). Since TAZ
has been characterized as a nuclear transactivator and colocalized
with ZO-2, we focused further experiments on ZO-2.
3.4. ZO-2 inhibits transactivation properties of TAZ
To investigate the effect of this interaction on the transactiva-
tion function of TAZ we used a gal4-fused TAZ construct in which
TAZ was fused to the minimal gal4 DNA binding domain. TAZ-gal4
strongly stimulated luciferase activity (Fig. 4A) as shown before
[17]. However, when gal4-TAZ was co-expressed with increasing
amounts of ZO-2 we observed a dramatic dose-dependent
decrease in gal4-dependent luciferase activity (Fig. 4A), indicating
that ZO-2 inhibits transcription activation activity of TAZ. Of note,
co-expression of TAZ with a ZO-2 deletion mutant that lacks the
ﬁrst PDZ domain elicited a much weaker inhibitory effect
(Fig. 4A). In a second approach we used a luciferase reporter
construct containing Runx2 response elements in the osteocalcin
promoter (p6OSE2-luc). Expression of osteocalcin is dependent
on the Runx2 transcription factor [18] and TAZ [2]. Cells transfec-Fig. 5. ZO-2 prevents nuclear translocation of TAZ in HEK cells. (A) Endogenous staining o
(green) and GST–TAZ (red). Nuclei were stained with DAPI. TAZ localizes predominantly
and cytoplasm in HEK cells transfected with GST–TAZ alone. Nuclei were stained with Dted with the reporter plasmid and Runx2 showed a threefold
increase in transcriptional activity over basal level (Fig. 4B).
Cotransfection with TAZ resulted in a dramatic increase in tran-
scriptional activity over basal levels. Coexpression with ZO-2
dramatically reduced activation to even lower levels than those
obtained with a TAZ construct lacking the PDZ binding motif
(Fig. 4B). Cotransfection of ZO-2 without the ﬁrst PDZ domain
was still able to inhibit transcriptional activity, although to a les-
ser extent than the wild type.
To investigate if the observed inhibition might be due to trans-
location of TAZ-induced by ZO-2, we transfected HEK293T cells
with HA tagged ZO-2 and GST tagged TAZ. We observed that HA
ZO-2 prevented nuclear translocation of TAZ concomitant with a
redistribution to the cytosol (Fig. 5B). In cells that did not express
the ZO-2 construct, GST TAZ localized to the nucleus as well
(Fig. 5C). Localization of endogenous ZO-2/TAZ is shown in
Fig. 5A. These ﬁndings indicate that ZO-2 can control the subcellu-
lar location of TAZ.
Since overexpressed ZO-2 leads to inhibition of TAZ-mediated
transactivation we were curious to see if knocking down ZO-2 pro-
tein levels would result in stimulation of TAZ activity. Human
embryonic kidney (HEK) cells transduced with a short hairpin
targeting ZO-2 or a control short hairpin were used for this purpose
(Supplementary Fig. 3B). Luciferase values did not differ signiﬁ-
cantly from control (Supplementary Fig. 3A).
4. Discussion
Our results indicate that the PDZ binding motif of TAZ is rec-
ognized by the ﬁrst PDZ domain of ZO-1 and ZO-2. Transactivatorf ZO-2 (green) and TAZ (red). (B) HEK cells were co-transfected with HA tagged ZO-2
to the cytoplasm under these conditions. (C) GST–TAZ (red) localizes to the nucleus
API. The left panel shows background HA staining. Size bar = 10 lm.
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gene expression. ZO-2 down regulation did not provoke increased
TAZ activity. Perhaps differences in transcription activation only
surface in cells with complete silencing of ZO-2 instead of partial
knockdown. In addition, other PDZ proteins like ZO-1 and MUPP1
might also be involved in regulation of TAZ. Since in Drosophila
only one homologue of ZO proteins is expressed (Tamou), it
would be interesting to study the effect of knocking down this
gene.
Both ZO-1 and -2 are able to interact with TAZ in a direct way
in vitro but surprisingly, endogenous ZO proteins did not co-
immunoprecipitate when endogenous TAZ was pulled down. One
possible explanation might be inadequacy of the antibodies to
detect the complex of ZO and TAZ. Another explanation might be
that coimmunoprecipitation experiments are prone to detect high
afﬁnity interactions [19]. Thus, the TAZ–ZO interaction might be of
a transient nature. This observation is similar to leucocyte phos-
photyrosine phosphatase (LCPTP), a tyrosine phosphatase that
interacts with MAP kinases [20]. Only when LCPTP was overex-
pressed, a fraction of endogenous MAP kinases could be immuno-
precipitated. Signal transduction events require low afﬁnity
interactions with sufﬁciently high off-rates [21], backing up the
hypothesis of a transient interaction between ZO proteins and
TAZ. These observations may also be context dependent because
in HEK cells ZO-2 is not encriched in the nucleus unlike in MDCK
cells. However, overexpression of ZO-2 resulted in a near depletion
of nuclear TAZ in these cells.
Additional proteins may be required to reinforce the interaction
between TAZ and ZO. The most straightforward class of proteins
that could build up such a tripartite complex are transcription fac-
tors. c-Jun is an interesting candidate as a ‘‘bridging” protein since
it also comprises PPxY motifs endowing it to bind WW domain
containing proteins. Altogether, networking between TAZ and
ZO-1 and ZO-2 offers a promising target in the control of prolifer-
ation and apoptosis, epithelial-mesenchymal transition and migra-
tion capacity of cancer cells.
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